An Open-Label Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]-JNJ-70099731 in Healthy Male Participants
Latest Information Update: 23 Feb 2022
Price :
$35 *
At a glance
- Drugs 18F JNJ 70099731 (Primary)
- Indications Unspecified
- Focus Diagnostic use
- Sponsors Janssen Research & Development
- 17 Feb 2022 Status changed from recruiting to completed.
- 04 Jan 2022 Planned End Date changed from 26 Nov 2021 to 1 Feb 2022.
- 04 Jan 2022 Planned primary completion date changed from 19 Nov 2021 to 25 Jan 2022.